Clinical Trials
1,358 trialsCAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer
Peking Union Medical College Hospital
P-RALP
Instituto do Cancer do Estado de São Paulo
PRO-P
Heinrich-Heine University, Duesseldorf
The Efficacy and Safety of Liangxue Ointment in the Treatment of Hand-foot Syndrome Caused by VEGFR-TKI Drugs
Peking University Cancer Hospital & Institute
The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma
Wuhan Ammunition Life-tech Co., Ltd
The Safety and Dosimetry Study of 177Lu-LNC1003 Injection
Yantai LNC Biotechnology Singapore PTE. LTD.
SAMPHYR
University Hospital, Caen
MicroStyle
European Institute of Oncology
A Study of HY-0102 in Patients With Advanced Solid Tumors
Shanghai YingLi Pharmaceutical Co. Ltd.
Retrospective Registry Study of Patients With Cancer Treated With High-dose Methotrexate
BTG International Inc.
A Study of Pembrolizumab+ sEphB4 in Metastatic Urothelial Carcinoma
Vasgene Therapeutics, Inc
Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma
Peking University First Hospital
LUCIDA
FutureChem
LUCIDA_2
FutureChem
Characterization of Prostate Cancer With 3T MR
Beth Israel Deaconess Medical Center
To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer
The First Affiliated Hospital of Xiamen University
The Effect of IBD Flares on Serum PSA
Northwestern University
Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients
Dokuz Eylul University
A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery
Sun Yat-sen University
Decade-Long Insights Into Transperineal Prostate Biopsy in a West China Population
West China Hospital
Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide
Instituto do Cancer do Estado de São Paulo
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
Multi-parametric MRI in Patients of Bladder Cancer
The First Affiliated Hospital with Nanjing Medical University
Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma
West China Hospital
Effect of Optimized PEEP on Mechanical Ventilation During Robot Assisted Laparoscopic Prostatectomy
Gangnam Severance Hospital
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohorts
Promontory Therapeutics Inc.
SILENTEMPIRE
University of Zurich
CKD AGE
Centre Hospitalier Saint Joseph Saint Luc de Lyon
Randomized Pilot Study of Radiosurgery for the Treatment of Non-metastatic Prostate Cancer
Pontificia Universidad Catolica de Chile
Two-step RP
Sun Yat-sen University
EVALUATION
Pharmalink
Phase 1 Study Evaluating Safety and Tolerability of SL-T10, GX-I7, and Pembrolizumab Triple Combination in mCRPC.
SL VAXiGEN
ONFM-SBRT
Peking University Third Hospital
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
immunoBLAD
Centre Hospitalier Universitaire de Besancon
Renal Autotransplantation; Case Series
Methodist Health System
STRONG-CS
Bispebjerg Hospital
HyBraFi
CHU de Quebec-Universite Laval
Thulium Beam Coagulation Versus Suture Renorrhaphy for Hemostasis of Tumor Bed in Laparoscopic Partial Nephrectomy
Al-Azhar University
Cryoablation Versus BCG Instillation Therapy for High-risk NMIBC
Huashan Hospital
HYPOSTAT-II
University Hospital Schleswig-Holstein
MIKAPOCo
IRCCS Ospedale San Raffaele
POSITive
European Institute of Oncology
Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy
Peking University First Hospital
Tumor TARGET Prostate Cancer
University Health Network, Toronto
An Evaluation of the Efficacy and Safety of Apalutamide as Neoadjuvant Endocrine Therapy in High-Risk and Oligometastatic Prostate Cancer
Zhujiang Hospital
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
Eutilex
Efficacy and Safety of Apalutamide in Combination With 89Sr as Neoadjuvant Therapy in Prostate Cancer With ≤10 Bone Metastases
Zhujiang Hospital
Comparison of Spinal Anesthesia and Spermatic Cord Block for Bilateral Orchiectomy
Sanpasitthiprasong Hospital